FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ralph Levitt

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Disorders

Activities & Behaviors

Drug Evaluation

Co-author Network

Publications

TOP 3
Charles L Loprinzi; Dennis F Moore; Jeff A Sloan; Philip J Stella; Robin T Zon; Ernie P Balcueva; Mark D Carlson; Lisa A Kottschade; Ralph Levitt; Heshan Liu; Anthony J Jaslowski
A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA.
Steven R Alberts; Paul J Novotny; Jeff A Sloan; John Danella; David G Bostwick; Thomas J Sebo; Michael L Blute; Tom R Fitch; Ralph Levitt; Ronald Lieberman; Charles L Loprinzi
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
Kostandinos Sideras; Paul L Schaefer; Scott H Okuno; Jeff A Sloan; Leila Kutteh; Tom R Fitch; Shaker R Dakhil; Ralph Levitt; Steven R Alberts; Roscoe F Morton; Kendrith M Rowland; Paul J Novotny; Charles L Loprinzi
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ralph Levitt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Charles L Loprinzi; Dennis F Moore; Jeff A Sloan; Philip J Stella; Robin T Zon; Ernie P Balcueva; Mark D Carlson; Lisa A Kottschade; Ralph Levitt; Heshan Liu; Anthony J Jaslowski
A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA.
The journal of supportive oncology 2011;9(3):105-12.
2006: Steven R Alberts; Paul J Novotny; Jeff A Sloan; John Danella; David G Bostwick; Thomas J Sebo; Michael L Blute; Tom R Fitch; Ralph Levitt; Ronald Lieberman; Charles L Loprinzi
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
American journal of therapeutics 2006;13(4):291-7.
2006: Kostandinos Sideras; Paul L Schaefer; Scott H Okuno; Jeff A Sloan; Leila Kutteh; Tom R Fitch; Shaker R Dakhil; Ralph Levitt; Steven R Alberts; Roscoe F Morton; Kendrith M Rowland; Paul J Novotny; Charles L Loprinzi
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.
Mayo Clinic proceedings. Mayo Clinic 2006;81(6):758-67.
2006: Charles L Loprinzi; Ralph Levitt; Debra L. Barton; Jeff A Sloan; Shaker R Dakhil; Daniel A Nikcevich; James Bearden; James A Mailliard; Loren K Tschetter; Tom R Fitch; John W Kugler
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1409-14.
2005: Steven R Alberts; William L Horvath; William C Sternfeld; Richard M Goldberg; Michelle R Mahoney; Shaker R Dakhil; Ralph Levitt; Kendrith M Rowland; Suresh Nair; Daniel J Sargent; John H Donohue
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9243-9.
2005: Charles L Loprinzi; Ralph Levitt; Debra L. Barton; Jeff A Sloan; Pamela J Atherton; Denise J Smith; Shaker R Dakhil; Dennis F Moore; James E Krook; Kendrith M Rowland; Miroslaw A Mazurczak; Alan R Berg; George P Kim
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial.
Cancer 2005;104(1):176-82.
2005: Steven R Alberts; Hani Al-Khatib; Michelle R Mahoney; Lawrence J Burgart; Peter J Cera; Patrick J Flynn; Tom R Finch; Ralph Levitt; Harold E Windschitl; James A Knost; Loren K Tschetter
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
Cancer 2005;103(1):111-8.
2004: Edith A Perez; Francois J Geoffroy; Shauna Hillman; Elizabeth A Johnson; Gist Henry Farr; Henry D Tazelarr; Alan K Hatfield; James E Krook; James A Maillard; Ralph Levitt; Randolph S Marks
Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):347-53.
2003: James R Jett; Alan K Hatfield; Shauna Hillman; Michael D Bauman; James A Mailliard; John W Kugler; Roscoe F Morton; Randolph S Marks; Ralph Levitt
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Cancer 2003;97(10):2498-503.
2003: Gary A Croghan; Jeff A Sloan; Ivana T Croghan; Paul J Novotny; Richard D Hurt; Wanda L DeKrey; James A Mailliard; Larry P Ebbert; Debra K Swan; Daniel J Walsh; Martin Wiesenfeld; Ralph Levitt; Philip J Stella; Patricia A. Johnson; Loren K Tschetter; Charles L Loprinzi
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2003;5(2):181-7.
2003: Jan C Buckner; Dean H Gesme; Judith R O'Fallon; Julie E Hammack; Scott L Stafford; Paul D. Brown; Roland Hawkins; Bernd W Scheithauer; Bradley J Erickson; Ralph Levitt; Edward G Shaw; Robert Jenkins
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):251-5.
2002: Harry J Long; Sandra Rayson; Karl C Podratz; Samir Abu-Ghazaleh; Vera J Suman; Lynn C Hartmann; Ralph Levitt; Suresh Nair; Alan K Hatfield; James A Knost
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
American journal of clinical oncology 2002;25(6):547-51.
2002: Scott H Okuno; James A Mailliard; Vera J Suman; John H Edmonson; Edward T. Creagan; Suresh Nair; Ralph Levitt; John W Kugler
Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Cancer 2002;94(8):2224-31.
2002: Carmen J Allegra; Allyson L Parr; Lester E Wold; Michelle R Mahoney; Daniel J Sargent; Patrick Johnston; Pamela Klein; Katie Behan; Michael J O'Connell; Ralph Levitt; John W Kugler; Maria Tria Tirona; Richard M Goldberg
Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1735-43.
2001: Ayalew Tefferi; C Y Li; C B Reeder; Susan M Geyer; Cristine Allmer; Ralph Levitt; John C Michalak; Ferdinand K Addo; James E Krook; Thomas E Witzig; Paul L Schaefer; James A Mailliard
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia.
Leukemia 2001;15(8):1171-5.
2001: John H Edmonson; Vera J Suman; Robert J Dalton; W C Bro; Mary M Gallenberg; Harry J Long; Ralph Levitt; Alan K Hatfield; James E Krook; James A Mailliard; JB Gerstner
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.
Cancer investigation 2001;19(6):597-602.
2000: James A Martenson; John W Bollinger; Jeff A Sloan; Paul J Novotny; R E Urias; John C Michalak; Thomas G Shanahan; James A Mailliard; Ralph Levitt
Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1239-45.
1999: Ayalew Tefferi; Ralph Levitt; Chin-Yang Li; Georgene Schroeder; Loren K Tschetter; John C Michalak; James E Krook; Thomas E Witzig
Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia.
American journal of clinical oncology 1999;22(5):509-16.
1999: James A. Bonner; Jeff A Sloan; Thomas G Shanahan; Burke J Brooks; Randolph S Marks; James E Krook; JB Gerstner; Andrew W Maksymiuk; Ralph Levitt; James A Mailliard; Henry D Tazelaar; Shauna Hillman; James R Jett
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2681-91.
1999: James A Martenson; Thomas G Shanahan; Michael J O'Connell; Charles D Cobau; Georgene Schroeder; Patrick A Burch; Ralph Levitt; Kendrith M Rowland
Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy.
Cancer 1999;86(4):710-4.
1999: Arie Perry; Robert B Jenkins; Judith R O'Fallon; Paul L Schaefer; David W Kimmel; Michelle R Mahoney; Bernd W Scheithauer; S M Smith; E M Hill; T J Sebo; Ralph Levitt; James E Krook; Loren K Tschetter; Roscoe F Morton; Jan C Buckner
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.
Cancer 1999;86(4):672-83.
1999: Charles L Loprinzi; John W Kugler; Jeff A Sloan; Thom W Rooke; Susan K Quella; Paul J Novotny; R B Mowat; John C Michalak; Philip J Stella; Ralph Levitt; Loren K Tschetter; Harold E Windschitl
Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.
The New England journal of medicine 1999;340(5):346-50.
1999: RF Marschke; JP Grill; Jeff A Sloan; Donald B Wender; Ralph Levitt; James A Mailliard; JB Gerstner; C Ghosh; Roscoe F Morton; James R Jett
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer.
American journal of clinical oncology 1999;22(1):15-7.
1997: Henry C Pitot; Donald B Wender; Michael J O'Connell; Georgene Schroeder; Richard M Goldberg; Joseph Rubin; James A Mailliard; James A Knost; C Ghosh; RJ Kirschling; Ralph Levitt; Harold E Windschitl
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2910-9.
1997: Lynn C Hartmann; Loren K Tschetter; T M Habermann; Larry P Ebbert; P S Johnson; James A Mailliard; Ralph Levitt; Vera J Suman; Thomas E Witzig; HS Wieand; Langdon L Miller; CG Moertel
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
The New England journal of medicine 1997;336(25):1776-80.
1996: Terrence L Cascino; Michael H Veeder; Jan C Buckner; Judith R O'Fallon; M Wiesenfeld; Ralph Levitt; Richard M Goldberg; Steven A Kuross; Roscoe F Morton; Bernd W Scheithauer
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.
Journal of neuro-oncology 1996;30(3):243-6.
1995: R K Sylvester; Ralph Levitt; P D Steen
Opioid-induced muscle activity: implications for managing chronic pain.
The Annals of pharmacotherapy 1995;29(11):1118-21.
1995: Louis Letendre; Ralph Levitt; R V Pierre; Georgene Schroeder; J A Krook; J E Mailliard; Roscoe F Morton; Loren K Tschetter
Myelodysplastic syndrome treatment with danazol and cis-retinoic acid.
American journal of hematology 1995;48(4):233-6.
1995: Edward G Shaw; R L Deming; Edward T. Creagan; S Nair; J Q Su; Ralph Levitt; P D Steen; M Wiesenfeld; James A Mailliard
Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer.
International journal of radiation oncology, biology, physics 1995;31(4):827-31.
1995: Ralph Levitt; Jan C Buckner; Terrence L Cascino; Patrick A Burch; Roscoe F Morton; M W Westberg; Richard M Goldberg; J G Gallagher; Judith R O'Fallon; B W Scheithauer
Phase II study of amonafide in patients with recurrent glioma.
Journal of neuro-oncology 1995;23(1):87-93.
1994: James R Jett; A W Maksymiuk; J Q Su; James A Mailliard; James E Krook; Loren K Tschetter; Carl G Kardinal; D I Twito; Ralph Levitt; JB Gerstner
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2321-6.
1994: L D Erickson; Lynn C Hartmann; J Q Su; S N Nielsen; D M Pfeifel; Richard M Goldberg; Ralph Levitt; C Robert Stanhope
Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma.
Gynecologic oncology 1994;54(2):196-200.
1994: H J Long; R A Nelimark; J Q Su; S C Garneau; Ralph Levitt; Richard M Goldberg; M A Poon; John W Kugler
Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinoma.
Gynecologic oncology 1994;54(2):180-3.
1994: T R Buroker; Michael J O'Connell; H S Wieand; James E Krook; JB Gerstner; James A Mailliard; Paul L Schaefer; Ralph Levitt; Carl G Kardinal; Dean H Gesme
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):14-20.
1991: M A Poon; Michael J O'Connell; H S Wieand; James E Krook; JB Gerstner; Loren K Tschetter; Ralph Levitt; Carl G Kardinal; James A Mailliard
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(11):1967-72.
1991: H J Long; J A Laurie; H S Wieand; J H Edmonson; Ralph Levitt; James E Krook; S Abu-Ghazaleh
A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
Cancer 1991;68(4):730-2.
1991: T E Elliott; Jan C Buckner; Terrence L Cascino; Ralph Levitt; Judith R O'Fallon; B W Scheithauer
Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.
Journal of neuro-oncology 1991;10(1):27-30.
1990: S R Patel; L K Kvols; Richard G Hahn; Harold E Windschitl; Ralph Levitt; Terry M Therneau
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.
Cancer 1990;66(4):655-8.
1986: James A Mailliard; Louis Letendre; Robert J Dalton; Ralph Levitt; JB Gerstner; Terry M Therneau; R V Pierre
Phase I-II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia.
Medical and pediatric oncology 1986;14(6):306-9.
1980: M R Wick; C Y Li; J Ludwig; Ralph Levitt; R V Pierre
Malignant histiocytosis as a terminal condition in chronic lymphocytic leukemia.
Mayo Clinic proceedings. Mayo Clinic 1980;55(2):108-12.